Regenerative Medical Technology Group

Building the global infrastructure for regenerative medicine. Physician education (ISSCA), biotech (Cellgenic) and clinical care (Cellular Institute). $RMTG

[Regenerative Medical Technology Group @RMTGOfficial]

📈 $RMTG More Than Quadruples Revenue and Gross Profit in Q2 2026 Versus Q2 2025, With Operating Income Surpassing $560,000 🔥

Continued Acceleration in 2026 With Record Revenue, Expanding Margins, Growth in Operating Profit, and Accelerating Training and Product Supply Sales🤑

📢 Today's Press Release https://t.co/KRNjjxFYzh

[Regenerative Medical Technology Group @RMTGOfficial]

$RMTG Watch the interview with Dave Christensen our CEO/President talking about his personal experience with what he calls his "Ride-or-Die" Peptide. TA-1 🏆

https://t.co/Tt25gyGsBh

[Regenerative Medical Technology Group @RMTGOfficial]

$RMTG's ISSCA Division Announces Successful Santa Cruz, Bolivia Conference, October 23-24 🇧🇴

📣 A new country on ISSCA's calendar extends the division's market-by-market Latin American education cadence.

https://t.co/F40OgL4pXs

[Regenerative Medical Technology Group @RMTGOfficial]

$RMTG ❤️ This is a huge clarification on the real focus of who we are. We are an organization dedicated to "Cellular Healing" ❤️

https://t.co/A9iCZDsl8B

[Regenerative Medical Technology Group @RMTGOfficial]

$RMTG's ISSCA 🎓 Division Returns to São Paulo for a Second Brazil 🇧🇷 Congress, November 20-21

A second Brazil event in a single year - a frequency ISSCA has not previously applied - underscores Brazil's priority alongside Cellgenic's permanent operations there. 📈

https://t.co/VpFNi8UMsd

[Regenerative Medical Technology Group @RMTGOfficial]

$RMTG Q2 2026, by the numbers.

Revenue: $4.02M, up 309% from Q2 2025.
Gross profit: $2.58M, a 64% gross margin.
Income from operations: $566K, up from an operating loss a year earlier.

Growth came from every line of business:

Training (ISSCA): up 860% to $1.30M
Product supplies (Cellgenic): up 421% to $2.10M
Patient procedures (Cellular Institute): up 42% to $620K

One platform connecting physician education, biotechnology and clinical care through Global Stem Cells Group.

Full results in our Q2 Form 10-Q: https://t.co/rZ524wgmg9
#OTC #Peptides #Pennystocks

[Regenerative Medical Technology Group @RMTGOfficial]

@HulkInvestments The advent of AI has fundamentally reshaped small cap traders relationship with the OTC. You have an absurd amount of DD with a single prompt now.

[Regenerative Medical Technology Group @RMTGOfficial]

@cdntradegrljenn Happens with no bid or when the pps manages to dip past trips. Usually from a conversion. I've seen it a few times before.

[Regenerative Medical Technology Group @RMTGOfficial]

Why is a regenerative medicine company ringside?

In September 2025, $RMTG partnered with @bareknucklefc , the world's leading bare knuckle promotion. The partnership is built around something every fighter cares about: athlete health, recovery and long-term performance.

That's the business we're in. Through Global Stem Cells Group, RMTG connects four operating businesses:

ISSCA: physician education and certification
Cellgenic: biotechnology with in-house cGMP manufacturing
Cellular Institute: clinical care for patients
Stem Cell Center: a provider network bringing regenerative medicine to the point of care

Learn more: https://t.co/yreP0oyKtR

[Regenerative Medical Technology Group @RMTGOfficial]

$RMTG's ISSCA is the 🌐 world's largest Regenerative Medicine Training Organization! 🎓

Taught live, by the doctors 🥼who are actually writing the protocols 💉📋

https://t.co/mNfLQ0chIS

https://t.co/hGzXuMgvSu

[Regenerative Medical Technology Group @RMTGOfficial]

$RMTG to Go Ringside at 👊🏽💥 BKFC This Weekend to Capture Content for Its "RMTG Brief" Investor-Awareness Campaign 📈

https://t.co/1mxMzFxN29

[Digital Asset Monetary Network @OTC_DATI]

@RMTG_RegenMedTG describes ISSCA AI™ as more than a generic AI layer: a physician-controlled system intended to incorporate ISSCA protocols and workflows. The design is notable; validation and adoption remain to be shown.
Learn more:
https://t.co/XshxFnt2GB

$DATI $RMTG #DigitalAMN

[Regenerative Medical Technology Group @RMTGOfficial]

@chloecupcak Hahaha... you don't know Dave. He's is big as life and as real as they come. Go here to see real content recorded live with him.

https://t.co/6WIVcKcNVi

https://t.co/5AHCYauKT7

https://t.co/HgRGg4OmO8

[Regenerative Medical Technology Group @RMTGOfficial]

$RMTG ISSCA 125 with our CEO Dave Christensen 🔥

[Regenerative Medical Technology Group @RMTGOfficial]

@ariell_xyz Dave is a major connector of people. He connects world famous doctors and medical professionals with doctors new to Regenerative Medicine and often 1st time ISSCA attendees. Please come to our next event and see for yourself. See next event schedule here:

https://t.co/mNfLQ0chIS

[Regenerative Medical Technology Group @RMTGOfficial]

@mozo2say Haha... apparently you missed our 10-Q results? More revenue in 1st half of 2026 than all of 2025.

See:
https://t.co/PSwLAgGhNt

[Regenerative Medical Technology Group @RMTGOfficial]

@superpobe He is the CEO and President of RMTG, the parent company of ISSCA.

SEE: https://t.co/k1Lt6R2KR9

[Regenerative Medical Technology Group @RMTGOfficial]

$RMTG's ISSCA Division Expands Global Online Academy With Ten New Curriculum Tracks 📃

A digital-first expansion scales physician education 👨‍🎓 beyond ISSCA's in-person markets, diversifying the education segment toward higher-margin, travel-independent revenue.

https://t.co/4MmWJkSdF3

The ten new modules represent a substantial content investment rather than an incremental update!

[Regenerative Medical Technology Group @RMTGOfficial]

Hi Nate, love the HP reference.😆 We are trying to make front-page news for "The Daily Prophet" 😉 You are right that we have been heads down building the actual real business, and the numbers prove that. In just the first half of 2026 we exceeded all of revenue for 2025. We expect that trend to continue and we appreciate your loyalty and we are preparing to "Send out the owls" 📈

[Regenerative Medical Technology Group @RMTGOfficial]

$RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies 📃

📋 New ISSCA curriculum covers multiple adjunctive technologies used in longevity-focused practices and is intended to complement clinical capabilities Cellular Hope Institute is developing.

[Regenerative Medical Technology Group @RMTGOfficial]

$RMTG has 4 revenue streams:
1) ISSCA - the World's Largest Regenerative Medical Training Organization
2) Cellgenic - Two laboratories, one in Cancun, Mexico and the other in Buen Aires, Argentina. Both producing Regenerative Biologics (Stem Cells, Exosomes, Peptides)
3) Cellular Institute- our flagship clinic in Cancun, Mexico. The best protocols and patient treatments.
4) Stem Cell Centers - 29 other member network clinics globally.

[Regenerative Medical Technology Group @RMTGOfficial]

🔥 $RMTG our @isscaofficial is the Largest and Most Effective Reg Medical Training Organization in the World 🌐